Effect of zolpidem in patients with short-term insomnia;El efecto del zolpidem en los pacientes con insomnio de corta evolución

Salud Mental

Volumn 24, Issue 1, 2001, Pages 33-42

  Alvarez Rueda, J M ^a   Gutierrez Aguilar J ^a   Rosales, J ^a   Diaz Martinez A ^a   Lablache, B C ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Benzodiazepines; Pharmacology; Sleep; Sleep disorders; Treatment

Indexed keywords

BENZODIAZEPINE; FLUNITRAZEPAM; ZOLPIDEM;

ADULT; AGED; ARTICLE; DAILY LIFE ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; RATING SCALE; SLEEP DISORDER; SLEEP WAKING CYCLE;

EID: 0035052680     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. General safety profile of zolpidem: Safety in elderly, overdose and rebound effects
2. Las imidazodiazepinas, antagonistas centrales de las benzodiazepinas
3. Modificación de la densidad de los movimientos oculares rápidos bajo la administración de los agonistas y los antagonistas de los receptores a las benzodiazepinas
4. Análisis factorial de un cuestionario de hábitos de sueño
5. Sleep disorders
6. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo
7. Effect of zolpidem on sleep and sleep EEG spectra in healthy young men
8. The safety and tolerability of zolpidem - An update
9. Effects of zolpidem and flunitrazepam on nocturnal sleep of women subjectively complaining of insomnia
10. Short-term safety profile of zolpidem: Objective measures of cognitive effects
11. Comparison of the effects of zolpidem and flunitrazepam on sleep structure and daytime cognitive functions. A study of untreated insomniacs
12. Zolpidem and triazolam in humans: Behavioral and subjective effects and abuse liability
13. The effects of acute and repeated doses of zolpidem on subjective sleep psychomotor performance and cognitive function in elderly volunteers
14. Comparison of acute and residual effect on memory and attention of a single dose of zolpidem (10 mg) versus zopliclone, flunitrazepam and placebo
15. Safety and tolerance of zolpidem in the treatment of disturbed sleep: A post-marketing surveillance of 16944 cases
16. Hypnotics and sedatives; ethanol
17. Sueño normal y trastornos del sueño
18. Subjective versus objective evaluation of hypnotic efficacy: Experience with zolpidem
19. Recognition and diagnosis of insomnia
20. Rebound insomnia and newer hypnotics
21. Symptomatic treatment of insomnia
22. Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential
23. Apport du zolpidem dans la prise en charge des troubles du sommeil
24. Factor analysis of the St. Mary's Hospital sleep questionnaire
25. Effect of zolpidem (10 and 20 mg), lormetazepam, triazolam and placebo on night sleep and residual effects during the day
26. The safety and efficacy of zolpidem in insomniacs patientes: A long-term open study in general practice
27. Gamma-aminobutyric acid - A receptor heterogeneity in rat central nervous system: Studies with clonazepam and other benzodiazepine ligands
28. Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man
29. Statistical analysis of clinical trials
30. Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors
31. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure
32. Selective effects of zolpidem on human memory functions
33. Molecular and cellular basis of addiction
34. Drug addiction and drug abuse
35. Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics
36. Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem
37. Preoperative sedation before regional anaesthesia: Comparison between zolpidem, midazolam and placebo
38. The leeds sleep evaluation questionnaire in psychopharmacological investigation. A review
39. Zolpidem-place in therapy
40. Behavioral pharmacology of zolpidem relative to benzodiazepines: A review
41. Differential development of tolerance to the depressant effects of benzodiazepine and non-benzodiazepine agonists at the ommega (BZ) modulatory sites of GABA - A receptors
42. Dose response effects of zolpidem in normal geriatric subjects
43. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia
44. Long-term treatment of insomnia with zolpidem: A multicentre general practitioner study of 107 patients
45. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in patients
46. Evaluation of EEG cyclic alternating pattern during sleep in insomniacs and controls under placebo and acute treatment with zolpidem
47. Next day effects after night time treatment with zolpidem: A review
48. A/BDZ receptor on sleep in human subjects
49. Transient insomnia associated with a 3-hour phase advance of sleep time and treatment with zolpidem
50. Prevalence and health consequences of insomnia
51. Minimal rebound insomnia after treatment with 10-mg zolpidem